Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · IEX Real-Time Price · USD
5.51
+0.02 (0.36%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Ardelyx Revenue

Ardelyx had revenue of $159.11M in the twelve months ending March 31, 2024, with 152.32% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $46.02M with 304.81% year-over-year growth. In the year 2023, Ardelyx had annual revenue of $124.46M with 138.61% growth.

Revenue (ttm)
$159.11M
Revenue Growth
+152.32%
P/S Ratio
8.10
Revenue / Employee
$595,918
Employees
267
Market Cap
1.29B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 20182.61M-39.39M-93.79%
Dec 31, 201742.00M--
Dec 31, 20160--
Dec 31, 201524.03M-7.60M-24.02%
Dec 31, 201431.62M2.70M9.32%
Dec 31, 201328.93M23.52M434.71%
Dec 31, 20125.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Omnicell 1.10B
ANI Pharmaceuticals 517.46M
Arcus Biosciences 237.00M
Establishment Labs Holdings 155.79M
Gyre Therapeutics 140.62M
Prothena Corporation 89.25M
Immatics 80.95M
Ocular Therapeutix 59.84M
Revenue Rankings